Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial

Study objective: The objective was to assess the effect of ongoing angiotensin receptor-neprilysin inhibitor(ARNI) on the effect of the sodium glucose cotransporter 2 (SGLT2) inhibitor empagliflozin on left ventricular (LV) size and function in patients with heart failure and reduced ejection fracti...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Julie Hempel Larsen, Massar Omar, Jesper Jensen, Camilla Fuchs Andersen, Caroline Michaela Kistrup, Mikael Kjær Poulsen, Lars Videbæk, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-02-01
סדרה:	American Heart Journal Plus
נושאים:	Heart failure Sodium-glucose cotransport 2 inhibitor Angiotensin Receptor-Neprilysin Inhibitor Sacubitril Valsartan
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2666602223000162
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!